Showing results (151-160 of 232) with videos related to
Sort By:
Pageof 24
Pathology|April 1, 1985
Prognostic histopathological factors in malignant melanomaH M Shaw, C M Balch, S J Soong, et al.International Journal of Cancer|August 1, 1994
Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanomaD D Kharkevitch, D Seito, G C Balch, et al.Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1990
Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision aloneM J Edwards, S J Soong, A W Boddie, et al.Microvascular Research|November 1, 1996
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristicsF J Candal, S Rafii, J T Parker, et al.Vaccine|May 17, 2000
Competition among Streptococcus pneumoniae for intranasal colonization in a mouse modelM Lipsitch, J K Dykes, S E Johnson, et al.Gastroenterology|June 1, 1984
Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's diseaseS P James, L M Neckers, A S Graeff, et al.Archives of Pathology & Laboratory Medicine|September 26, 2001
Malignant melanomaA Slominski, J Wortsman, A J Carlson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanomaA Lipton, H A Harvey, C M Balch, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1995
Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamineD Risin, E S Kleinerman, Y Umezu, et al.Annals of Surgery|August 1, 1990
Survival following locoregional recurrence after breast conservation therapy for cancerA Stotter, E N Atkinson, B A Fairston, et al.Pageof 24